RWM
GOSS icon

Rialto Wealth Management’s Gossamer Bio GOSS Stock Holding History

Rialto Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38K Hold
20,552
– – ﹤0.01% 907
2026
Q1 		$6.75K Buy
20,552
+14,800
+257% +$23.3K ﹤0.01% 528
2025
Q4 		$17.8K Sell
5,752
-5,000
-47% -$14.3K ﹤0.01% 376
2025
Q3 		$28.3K Hold
10,752
– – 0.01% 313
2025
Q2 		$13.2K Hold
10,752
– – ﹤0.01% 391
2025
Q1 		$11.8K Hold
10,752
– – ﹤0.01% 391
2024
Q4 		$9.73K Buy
+10,752
New +$9.21K ﹤0.01% 397

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Rialto Wealth Management's GOSS Position: Q2 2026 in Review

Rialto Wealth Management held its Gossamer Bio (GOSS) position steady in Q2 2026 at 20,552 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Rialto Wealth Management first reported a position in GOSS in Q4 2024 and has held it in 7 quarters since. The position peaked at $28.3K in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Rialto Wealth Management held 20,552 shares of Gossamer Bio worth $3.38K as of Q2 2026.
  • Rialto Wealth Management left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #907 holding.
  • Rialto Wealth Management first reported a position in Gossamer Bio in Q4 2024 and has held it in 7 quarters since.
  • Rialto Wealth Management's Gossamer Bio position peaked at $28.3K in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.